Business Context and Reporting Period
This Form 8-K filing by Arrive AI Inc. (ARAI) reports a material event occurring on June 2, 2026. The Company, incorporated in Delaware and listed on The Nasdaq Global Market, received a deficiency notice regarding its continued listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance triggering the notice:
- Minimum Bid Price Requirement: $1.00 per share.
- Current Status: The closing bid price has remained below $1.00 for the last 30 consecutive business days.
Material Changes
The primary material change is the receipt of a deficiency letter from Nasdaq indicating non-compliance with Listing Rule 5450(a)(1) due to the low stock price. There is no immediate effect on the listing status; the stock remains fully effective on the Nasdaq Global Market.
Outlook, Risks, and Contingencies
Compliance Timeline: The Company has an initial 180-day compliance period ending on November 30, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days.
Contingencies: If the Company fails to comply by the deadline, it may be eligible for a second 180-day period, provided it meets all other initial listing standards (excluding the bid price requirement).
Risks: There is no assurance the Company will regain compliance. Failure to do so within the allotted periods could result in delisting. The Company intends to monitor the stock price and evaluate options to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of ARAI common stock relative to the $1.00 threshold.
- Monitor the Company's announcements regarding potential stock splits or other corporate actions intended to address the bid price deficiency.
- Track the Company's progress toward the November 30, 2026, compliance deadline.
- Review future filings for any updates on the Company's financial health or liquidity, which are not detailed in this specific 8-K.